You can get a prenatal DNA test as early as 8 weeks into pregnancy if you’re establishing paternity, or as early as 10 weeks for genetic screening. The exact timing depends on which type of test you need and how it’s performed. All of the earliest options use a simple blood draw from the mother’s arm, making them safe for both parent and baby.
Why 8 to 10 Weeks Is the Earliest Window
During pregnancy, fragments of the baby’s DNA naturally enter the mother’s bloodstream through the placenta. These tiny pieces, called cell-free fetal DNA, start circulating early but need time to build up to detectable levels. Before about 8 weeks, there simply isn’t enough of the baby’s DNA mixed in with the mother’s blood for a lab to isolate and analyze it reliably.
For paternity testing, labs can work with the amount of fetal DNA present at 8 weeks. For genetic screening, which looks for chromosomal conditions like Down syndrome, labs typically need a slightly higher concentration, which is why those tests start at 10 weeks.
Noninvasive Prenatal Paternity Testing
If your goal is to determine the biological father, a noninvasive prenatal paternity test can be done as early as the eighth week of pregnancy. The process involves a standard blood draw from the mother and a cheek swab (or blood sample) from the potential father. The lab separates the baby’s DNA fragments from the mother’s blood and compares them to the father’s sample. These tests are 99.9% accurate.
You’ll typically choose between two formats. A “peace of mind” test gives you results for personal knowledge only. You can sometimes collect the father’s sample at home, and the results come back faster, but they won’t hold up in court. A legal paternity test follows a chain-of-custody process: a certified professional collects all samples, verifies each person’s identity with a photo ID, and sends everything directly to an accredited lab with documented handling at every step. Both versions are equally accurate at 99.9%, but only the legal version produces court-admissible results for custody, child support, or other proceedings.
Genetic Screening With NIPT
Noninvasive prenatal testing, commonly called NIPT or NIPS, screens for chromosomal conditions starting at 10 weeks. It checks whether the baby has an increased risk of conditions caused by extra or missing chromosomes, including Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). Many labs also report the baby’s sex.
NIPT is a screening test, not a diagnostic one. That distinction matters. A screening test estimates whether your baby’s risk of a condition is higher or lower than average. It can produce false positives (flagging a risk that isn’t actually there) or false negatives (missing a condition that is present). A positive NIPT result doesn’t mean your baby definitely has a chromosomal condition. It means further diagnostic testing is recommended to confirm or rule it out.
Factors That Can Delay Testing
Even at 10 weeks, some women don’t have enough fetal DNA in their blood for the lab to return a result. When the concentration of baby’s DNA is too low, the lab will issue a “no call” result rather than an unreliable one, and you’ll need to wait and retest.
The biggest factor affecting fetal DNA concentration is maternal weight. Higher body weight is associated with lower fetal DNA levels, likely because the mother’s body releases more of its own DNA from fat cells, diluting the baby’s share. Other factors linked to lower concentrations include certain autoimmune conditions, blood-thinning medications like heparin, high cholesterol or triglyceride levels, and some hemoglobin disorders. If any of these apply to you, testing a week or two later can improve the chances of getting a clear result on the first try.
Diagnostic Tests: CVS and Amniocentesis
If a screening test flags a potential concern, or if you want definitive answers about your baby’s chromosomes, two diagnostic procedures can provide them. Unlike NIPT, these tests confirm or rule out genetic conditions rather than estimating risk.
Chorionic villus sampling (CVS) is available between weeks 10 and 13. A provider takes a tiny tissue sample from the placenta, which shares the baby’s DNA. The procedure carries a small risk of miscarriage, less than 1 in 100.
Amniocentesis is typically performed between weeks 15 and 20, though it can technically be done up until delivery. A provider uses a thin needle to withdraw a small amount of amniotic fluid, which contains fetal cells. The miscarriage risk is even lower than CVS, roughly 1 in 900 procedures. Other uncommon risks include minor leakage of amniotic fluid or slight bleeding, both of which typically resolve on their own.
Both procedures are also used for prenatal paternity testing when court-admissible DNA from the baby is needed through a diagnostic method, though the noninvasive blood test has largely replaced them for this purpose because it carries no miscarriage risk.
Quick Comparison by Timing
- 8 weeks: Noninvasive prenatal paternity test (blood draw from mother, cheek swab from father)
- 10 weeks: NIPT genetic screening (blood draw from mother)
- 10 to 13 weeks: CVS diagnostic test (placental tissue sample)
- 15 to 20 weeks: Amniocentesis diagnostic test (amniotic fluid sample)
What to Expect With Results
Noninvasive tests, whether for paternity or genetic screening, typically return results within one to two weeks. The blood draw itself takes minutes and feels like any routine lab work. There’s no recovery time and no risk to the pregnancy.
For CVS and amniocentesis, results can take one to three weeks depending on what the lab is analyzing. You may feel mild cramping after either procedure and are usually advised to rest for the remainder of the day. Most people return to normal activity within 24 hours.
If you’re unsure which test fits your situation, the key question is whether you need a screening estimate or a definitive answer, and whether your goal is genetic health information or establishing paternity. That narrows your options quickly, and the earliest blood-based versions of either test can be done in the first trimester with nothing more than a standard blood draw.